摘要
目的观察硫酸镁联合氨溴索治疗小儿喘憋性肺炎的临床疗效。方法选取2018年7月至2019年7月期间我院收治的50例喘憋性肺炎患儿作为研究对象,随机分为两组各25例。在常规治疗基础上,对照组予以硫酸镁治疗,观察组予以硫酸镁联合氨溴索治疗。比较两组的症状改善时间以及临床疗效。结果观察组的喘鸣音消失时间、体温恢复正常时间、心力衰竭持续时间及肺部阴影消失时间均显著短于对照组(P <0.05)。观察组的治疗总有效率为96.00%,显著高于对照组的76.00%(P <0.05)。结论硫酸镁联合氨溴索治疗喘憋性肺炎患儿的临床效果较硫酸镁单药治疗更为理想,值得临床推广应用。
Objective To observe the clinical efficacy of magnesium sulfate combined with ambroxol in the treatment of asthmatic pneumonia in children.Methods 50 children with asthmatic pneumonia admitted to our hospital from July 2018 to July 2019 were selected as research objects,and randomly divided into two groups,with 25 cases in each group.On the basis of regular treatment,the control group was treated with magnesium sulfate,and the observation group was treated with magnesium sulfate combined with ambroxol.The improvement time of symptoms and clinical efficacy were compared between the two groups.Results The disappearance time of wheezing,time of temperature returning to normal,duration of heart failure and disappearance time of lung shadow in the observation group were significantly shorter than those in the control group(P<0.05).The total effective rate of treatment of the observation group was 96.00%,significantly higher than 76.00%of the control group(P<0.05).Conclusions Magnesium sulfate combined with ambroxol in the treatment of children with asthmatic pneumonia has more ideal clinical effect than magnesium sulfate only,which is worthy of clinical promotion and application.
作者
江少青
JIANG Shaoqing(Department of Pediatrics,Puning People's Hospital,Jieyang 515300,China)
出处
《临床医学工程》
2020年第6期775-776,共2页
Clinical Medicine & Engineering
关键词
喘憋性肺炎
硫酸镁
氨溴索
临床疗效
Asthmatic pneumonia
Magnesium sulfate
Ambroxol
Clinical efficacy
